Search

everythinglearnresearchcommunity

for

Search:↓

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Microneedle technology has advanced for painless drug delivery and sensitive detection but faces a gap between experimental use and clinical needs.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Microneedles can precisely deliver cancer treatments with fewer side effects.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Liposome-based cosmeceuticals improve treatment effectiveness for skin and hair conditions.

Reducing reactive oxygen species can help treat nerve damage from platinum cancer drugs.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

The intestinal lymphatic system is active and promising for targeted drug delivery and therapies.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

The developed nasal gel improves cilostazol delivery to the brain, enhancing its effectiveness and reducing side effects.

Bioengineered microneedles and nanomedicine offer promising, precise treatments for tissue regeneration.

New cancer treatments aim to reduce side effects and improve effectiveness.

Cannabis, cryotherapy, and scalp cooling can help improve the quality of life for chemotherapy patients.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

Oncologists should better understand the unique impact of hair loss on Black breast cancer patients to offer more compassionate care.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

Injectable hydrogels are becoming increasingly useful in medicine for drug delivery and tissue repair.

Asian women with breast cancer experience the highest rates of long-term hair loss and related distress after chemotherapy.

Dermoscopy can help assess the severity of chronic radiation-induced skin damage in head and neck cancer patients.

Paclitaxel is an effective cancer drug with side effects and potential new uses beyond cancer.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Cancer prevention is crucial, with a focus on research and improved screening methods.